Development of Fenofibrate/Randomly Methylated β-Cyclodextrin-Loaded Eudragit<sup>®</sup> RL 100 Nanoparticles for Ocular Delivery
Fenofibrate (FE) has been shown to markedly reduce the progression of diabetic retinopathy and age-related macular degeneration in clinical trials and animal models. Owing to the limited aqueous solubility of FE, it may hamper ocular bioavailability and result in low efficiency to treat such disease...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2022-07-01
|
| Seri Bilgileri: | Molecules |
| Konular: | |
| Online Erişim: | https://www.mdpi.com/1420-3049/27/15/4755 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|